Overview
Libbe Englander is CEO and Founder at Pharm3r [1][2]. Englander holds a Ph.D. in Molecular Biology from The Rockefeller University [7] and a B.S. in Biology from Yale University [8]. Prior to founding Pharm3r in October 2011 [2], Englander served as Principal at CCHScience from 2008 to October 2011 [4], Managing Partner at NextStep Capital from March 2005 to November 2008 [5], and Founder and Portfolio Manager at BioPharma Capital from March 2000 to April 2005 [6]. Englander has served on the Robertson Therapeutic Development Fund Review Committee at Rockefeller University since January 2010 [3].
Career history
- CEO and FounderOct 2011 to presentPharm3r
- Robertson Therapeutic Development Fund Review CommitteeJan 2010 to presentRockefeller University
- Principal2008 to Oct 2011CCHScience
- Managing PartnerMar 2005 to Nov 2008NextStep Capital
- Founder and Portfolio ManagerMar 2000 to Apr 2005BioPharma Capital
Education
Ph.D., Molecular BiologyThe Rockefeller University
B.S., BiologyYale University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.